Skip to main content

Table 2 The correlation of mRNA expression of Kiss-1 and clinical parameters

From: Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer

Category   No. Median IQR p P a
T/Nb       
  Normal 80 97 6-2345   
  Tumour 94 35 1-2108 0.3775  
Paired T/Nb      
  Paired normal 68 82 6-2344   
  Paired tumour 68 8 0-1855 0.1672  
Location       
  Left colon 22 624 173-1968   
  Right colon 28 719 44-2000 0.899  
  Transcolonc 2 154 N/A 0.958  
  Rectum 22 673 175-2522 0.907  
Dukes classification      
  A 7 5539 848-24856   
  B 33 780 104-2272 0.043d  
  C 32 611 190-1221 0.015d  
Tumour stage      
  T1 2 8000 N/A   
  T2 10 1721 789-10369 1  
  T3 40 639 71-1332 0.226 0.0381d
  T4 18 592 215-1600 0.186  
Lymph node involvement      
  Node 0e 39 872 213-2874   
  Node 1e 16 715 67-1428 0.326  
  Node 2e 15 609 200-643 0.045d  
TNM staging      
  I 9 2081 814-20038   
  II 30 756 122-2473 0.06  
  III&IV 32 611 190-1221 0.009d  
Clinical outcome      
  No invasion 50 835 127-2372   
  Invasion 26 579 161-948 0.1907  
  Disease free 35 759 84-2081   
  Incidence 23 635 217-2187 0.8115  
  No recurrence 58 735 89-2373   
  Local recurrence 7 643 269-3718 0.604  
  No metastasis 50 735 84-2522   
  Metastasis 19 634.3 213-1463 0.92  
  Alive 36 661 86-1876   
  Death 22 572 195-1644 0.923  
  1. aTumour (T), Normal (N). bTransverse colon. c p < 0.05. dNode 0 stands for no node involvement; Node 1 stands for 1 to 3 lymph nodes close to the bowel found to contain cancer cells; Node 2 stands for more than 3 lymph nodes found to contain cancer cells and further than 3cm away from the main tumor in the bowel or the presence of cancer cells in lymph nodes connected to the main blood vessels around the bowel.